Literature DB >> 19622832

SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis.

Hailing Cheng1, Pixu Liu, Zhigang C Wang, Lihua Zou, Stephanie Santiago, Victoria Garbitt, Ole V Gjoerup, J Dirk Iglehart, Alexander Miron, Andrea L Richardson, William C Hahn, Jean J Zhao.   

Abstract

Resistance to anoikis, the subtype of apoptosis triggered by lack of adhesion, contributes to malignant transformation and the development of metastasis. Although several lines of evidence suggest that p53 plays a critical role in anoikis, the pathway(s) that connect cell detachment to p53 remain undefined. Here, through the use of a kinome-wide loss-of-function screen, we identify the serine-threonine kinase SIK1 (salt-inducible kinase 1) as a regulator of p53-dependent anoikis. Inactivation of SIK1 compromised p53 function in anoikis and allowed cells to grow in an anchorage-independent manner. In vivo, SIK1 loss facilitated metastatic spread and survival of disseminated cells as micrometastases in lungs. The presence of functional SIK1 was required for the activity of the kinase LKB1 in promoting p53-dependent anoikis and suppressing anchorage-independent growth, Matrigel invasion, and metastatic potential. In human cancers, decreased expression of the gene encoding SIK1 closely correlated with development of distal metastases in breast cancers from three independent cohorts. Together, these findings indicate that SIK1 links LKB1 to p53-dependent anoikis and suppresses metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19622832      PMCID: PMC2752275          DOI: 10.1126/scisignal.2000369

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  71 in total

1.  Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential.

Authors:  Zhi-Gang Zhuang; Gen-Hong Di; Zhen-Zhou Shen; Jian Ding; Zhi-Ming Shao
Journal:  Mol Cancer Res       Date:  2006-11       Impact factor: 5.852

2.  Molecular profiling of a tumor of unknown origin.

Authors:  Gustavo Ismael; Evandro de Azambuja; Ahmad Awada
Journal:  N Engl J Med       Date:  2006-09-07       Impact factor: 91.245

3.  The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death.

Authors:  P Karuman; O Gozani; R D Odze; X C Zhou; H Zhu; R Shaw; T P Brien; C D Bozzuto; D Ooi; L C Cantley; J Yuan
Journal:  Mol Cell       Date:  2001-06       Impact factor: 17.970

4.  HTLV-1 tax oncoprotein represses the p53-mediated trans-activation function through coactivator CBP sequestration.

Authors:  Y Ariumi; A Kaida; J Y Lin; M Hirota; O Masui; S Yamaoka; Y Taya; K Shimotohno
Journal:  Oncogene       Date:  2000-03-16       Impact factor: 9.867

Review 5.  Focal adhesion kinase: a potential target in cancer therapy.

Authors:  Maroesja J van Nimwegen; Bob van de Water
Journal:  Biochem Pharmacol       Date:  2006-09-25       Impact factor: 5.858

6.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

Authors:  Russell G Jones; David R Plas; Sara Kubek; Monica Buzzai; James Mu; Yang Xu; Morris J Birnbaum; Craig B Thompson
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

7.  The absence of p53 promotes metastasis in a novel somatic mouse model for hepatocellular carcinoma.

Authors:  Brian C Lewis; David S Klimstra; Nicholas D Socci; Su Xu; Jason A Koutcher; Harold E Varmus
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

8.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.

Authors:  Jose M Lizcano; Olga Göransson; Rachel Toth; Maria Deak; Nick A Morrice; Jérôme Boudeau; Simon A Hawley; Lina Udd; Tomi P Mäkelä; D Grahame Hardie; Dario R Alessi
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

9.  Systemic spread is an early step in breast cancer.

Authors:  Yves Hüsemann; Jochen B Geigl; Falk Schubert; Piero Musiani; Manfred Meyer; Elke Burghart; Guido Forni; Roland Eils; Tanja Fehm; Gert Riethmüller; Christoph A Klein
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

10.  Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas.

Authors:  Cristina M Contreras; Sushma Gurumurthy; J Marshall Haynie; Lane J Shirley; Esra A Akbay; Shana N Wingo; John O Schorge; Russell R Broaddus; Kwok-Kin Wong; Nabeel Bardeesy; Diego H Castrillon
Journal:  Cancer Res       Date:  2008-02-01       Impact factor: 12.701

View more
  69 in total

Review 1.  LKB1 signaling in advancing cell differentiation.

Authors:  Lina Udd; Tomi P Mäkelä
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

2.  LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma.

Authors:  Wenjin Liu; Kimberly B Monahan; Adam D Pfefferle; Takeshi Shimamura; Jessica Sorrentino; Keefe T Chan; David W Roadcap; David W Ollila; Nancy E Thomas; Diego H Castrillon; C Ryan Miller; Charles M Perou; Kwok-Kin Wong; James E Bear; Norman E Sharpless
Journal:  Cancer Cell       Date:  2012-06-12       Impact factor: 31.743

3.  Metformin impairs the growth of liver kinase B1-intact cervical cancer cells.

Authors:  Xuxian Xiao; Qiongqiong He; Changming Lu; Kaitlin D Werle; Rui-Xun Zhao; Jianfeng Chen; Ben C Davis; Rutao Cui; Jiyong Liang; Zhi-Xiang Xu
Journal:  Gynecol Oncol       Date:  2012-06-24       Impact factor: 5.482

Review 4.  Alternative cell death mechanisms in development and beyond.

Authors:  Junying Yuan; Guido Kroemer
Journal:  Genes Dev       Date:  2010-12-01       Impact factor: 11.361

Review 5.  Understanding micrometastatic disease and Anoikis resistance in ewing family of tumors and osteosarcoma.

Authors:  Sandra J Strauss; Tony Ng; Ariadna Mendoza-Naranjo; Jeremy Whelan; Poul H B Sorensen
Journal:  Oncologist       Date:  2010-05-17

Review 6.  Making sense of cancer genomic data.

Authors:  Lynda Chin; William C Hahn; Gad Getz; Matthew Meyerson
Journal:  Genes Dev       Date:  2011-03-15       Impact factor: 11.361

7.  Supervillin-mediated suppression of p53 protein enhances cell survival.

Authors:  Zhiyou Fang; Elizabeth J Luna
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

8.  SIK2 Restricts Autophagic Flux To Support Triple-Negative Breast Cancer Survival.

Authors:  Kimberly E Maxfield; Jennifer Macion; Hariprasad Vankayalapati; Angelique W Whitehurst
Journal:  Mol Cell Biol       Date:  2016-11-28       Impact factor: 4.272

9.  LKB1 inhibition of NF-κB in B cells prevents T follicular helper cell differentiation and germinal center formation.

Authors:  Nicole C Walsh; Lynnea R Waters; Jessica A Fowler; Mark Lin; Cameron R Cunningham; David G Brooks; Jerold E Rehg; Herbert C Morse; Michael A Teitell
Journal:  EMBO Rep       Date:  2015-04-26       Impact factor: 8.807

Review 10.  Contribution of p53 to metastasis.

Authors:  Emily Powell; David Piwnica-Worms; Helen Piwnica-Worms
Journal:  Cancer Discov       Date:  2014-03-21       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.